By Nick Paul Taylor
GlaxoSmithKline has struck a deal to buy Sierra Oncology for $1.9 billion for a near-approval cancer drug, completing a remarkable turnaround for the biotech and the Gilead castoff it bet its future on.
read more
By Fraiser Kansteiner
U.S. bankruptcy judge Michael Kaplan this week denied J&J’s bid to block a lawsuit accusing the company of hiding evidence that its industrial talc operations exposed workers to asbestos, Bloomberg first reported.
read more
By Andrea Park
The stateside approval comes nearly two and a half years after the Stimview XT software received CE mark clearance in Europe in late 2019.
read more
By Max Bayer
Ophthalmology-focused ProQR is axing 30% of its workforce, including its chief scientific officer, and re-strategizing, more than two months after its most developed asset, sepofarsen, failed to improve vision in kids with congenital eye disease in a phase 2/3 trial.
read more
By Fraiser Kansteiner
Life sciences investor Flagship Pioneering is breaking out the big guns. Days after enlisting execs from Ancestry.com and Novartis, the company has tapped one of its biggest CEO-partners since snagging former FDA commissioner Stephen Hahn, M.D., in June.
read more
By Andrea Park
San Francisco-based startup Mirvie is attempting to open up an earlier diagnostic window in the second trimester, in hopes of expanding the treatment options for patients predicted to experience preterm birth.
read more
By Angus Liu
Halozyme is best known for its under-the-skin drug delivery platform, with partnerships with the likes of Johnson & Johnson, GlaxoSmithKline and Roche. The company is now buying into the auto-injector realm and setting out to cultivate an internal commercial team.
read more
By Heather Landi
NEW YORK, New York—Northwell Health's JV, called Ascertain, plans to use $100 million to launch multiple AI companies in 2022 to tackle health inequities, with an initial focus on maternal health and chronic disease detection, executives announced Tuesday.
read more
By Conor Hale
By using AI to analyze dozens of proteins at once, Prevencio showed its blood test could be accurate in predicting whether a person with diabetes may have a heart attack or stroke within the coming year.
read more
By Dave Muoio
Nonfederal hospitals saw an 8.4% increase in drug spending during 2021 while clinics shouldered a 7.7% gain, according to a recent report from the American Society of Health-System Pharmacists.
read more
By Max Bayer
The Bristol Myers Squibb Foundation is expanding its two initiatives aimed at bolstering diversity among clinical trial investigators, adding Gilead as a sponsor.
read more
